Anglais | Français

Version HTML imprimable

Exporter le document en format HTML Aide


Baseline Assessment of the Nigerian Pharmaceutical Sector (WHO; 2002; 62 pages)
	Acknowledgements
	List of abbreviations
	Executive summary
	Introduction
		Nigeria: Country Profile
	THE HEALTH STATUS OF NIGERIANS
	Under-Five Morbidity and Mortality Rates
	BASIC HEALTH INDICATORS
		Demographic Indicators
		Socio-economic Indicators
		Health Status Indicators
		Morbidity indicators
		Mortality Indicators
	Structure of the health system in Nigeria
	DRUG SECTOR ORGANISATION
		The National Drug Policy
		Essential Drugs List (EDL)
		Legislation
		Medicine financing
		Pharmaceutical Research and Production
		Rational Use of Medicines
		Human Resources
	INTRODUCTION TO THE STUDY
		Study purpose and indicators
	STUDY DESIGN AND METHODOLOGY
		Scope and limitations
		Sampling procedure
		Training of Data Collectors and pre-testing of instruments
		Data Collection
		Analysis of Data
		Problems experienced
	RESULTS AND ANALYSIS ACCESS
		Availability of key drugs
		Expired drugs
		Affordability
		Household Survey
	QUALITY AND SAFETY
		Rational use of drugs indicators
		Prescribing of Drugs
		Patient Care
	INTERPRETATION OF RESULTS
		Access
		Quality and Safety
		Rational Use of Drugs
	CONCLUSIONS AND RECOMMENDED INTERVENTIONS
		Access and Quality
		Rational Use of Drugs
	ANNEX 1
		Forms for Level I Indicators
	ANNEX 2
		Survey Forms for Level II Indicators

Baseline Assessment of the Nigerian Pharmaceutical Sector

2002

PUBLISHED BY
THE FEDERAL MINISTRY OF HEALTH
IN COLLABORATION WITH
THE WORLD HEALTH ORGANISATION

Anglais | Français